Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Selective Serotonin Reuptake Inhibitors Combined With Antipsychotic Medication for the Treatment of Psychotic Depression

NCT00056472 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.

NCT NCT00056472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00056472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Selective Serotonin Reuptake Inhibitors Combined With Antipsychotic Medication for the Treatment of Psychotic Depression
Lead sponsor
Weill Medical College of Cornell University
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2003
Completion date
June 30, 2008
Enrollment
259 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder with psychotic features